Menin-MLL inhibitor 29
Menin-MLL inhibitor 29 (Compound C1) is a Menin-MLL PPI inhibitor. Menin-MLL inhibitor 29 binds to Menin with a KD value of 138 nM, and inhibits the binding of Menin to MBM1 (Menin-binding motif 1) with an IC50 value of 46 nM. Menin-MLL inhibitor 29 inhibits HepG2 and Hep3B hepatoma cell proliferation (IC50s: 0.31 μM and 0.71 μM) . Menin-MLL inhibitor 29 inhibits tumor growth[1].
Product Specifications
UNSPSC
12352005
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/menin-mll-inhibitor-29.html
Solubility
10 mM in DMSO
Smiles
Molecular Formula
C36H26Br2F6N4PRh
Molecular Weight
922.30
References & Citations
[1]Zhong HJ, et al. Development of an orally bioavailable selective inhibitor of the menin-MLL. Genes Dis. 2022 Oct 18;10 (5) :1735-1738.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Browse additional items from our catalog
ZNF307 (Zinc Finger Protein 307, Zinc Finger Protein 427, ZNF427, Zinc Finger Protein with KRAB and SCAN Domains 4, ZKSCAN4, P373c6.1) (FITC)
Camel Dual Specificity Phosphatase 1 ELISA Kit